<DOC>
	<DOCNO>NCT02183805</DOCNO>
	<brief_summary>Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill tumor cell .</brief_summary>
	<brief_title>Chemotherapy Followed Peripheral Stem Cell Transplantation Treating Metastatic Triple-negative Breast Cancer</brief_title>
	<detailed_description>To explore progression-free survival patient metastatic triple-negative breast cancer treat peripheral blood stem cell transplant ( PBSCT ) follow high dose chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Triple Negative Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Eastern Cooperative Oncology Group ( ECOG ) 0 1 . Histologically cytologically proven diagnosis breast cancer evidence locally recurrent metastatic disease . Documentation estrogen progestin receptor ( ER/PR ) negative status HER2/neu receptor negative status ( ie , FISH negative immunohistochemistry 0 +1 ) . Obtained complete response Good partial response first line chemotherapy . Normal organ function require prior study entry . Willingness comply treatment plan study procedure . Uncontrolled central nervous system ( CNS ) involvement disease Fertile woman unwilling use contraceptive technique treatment Females pregnant Organ dysfunction . Patients may receive investigational agent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>triple negative breast cancer</keyword>
	<keyword>autologous hematopoietic stem-cell transplantation</keyword>
</DOC>